Asthma Devices Market 2018 - Healthy Growth seen in Europe and Worldwide Outlook up to 2023

Asthma Devices Market Set for Rapid Growth, Regional Analysis, Manufacturing Methods and Key Players. Asthma Device Market Research Report: By Type (Inhalers, Nebulizers, Dry Powder Inhalers, Metered-Dose Inhalers, Mesh Nebulizers) By Technology (Manually Operated, Digitally Operated) By End Users (Hospital, Retail Pharmacies) – Global Forecast till 2023

Global Asthma Devices Market is segmented on the basis of type, technology, and end users. On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, and metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others. On the basis of technology, the market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others. On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.

Key players for global asthma devices market

GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.

Request Sample copy of Asthma Devices Market Report@ https://www.marketresearchfuture.com/sample_request/1624 .

Market Scenario:

Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of asthma is one of the major drivers for the market growth. According to the World Health Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the market growth. However, long treatment procedures and low per capita income followed by lack of favorable reimbursement policies in the developing countries will restrain the market growth during the forecast period.

Regional Analysis:

The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases. According to the Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total population in the U.S. was identified for the presence of asthma. Moreover, changing lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the presence of global players like Merck & Co., Inc. and Baxter, and others boost market growth during the forecast period.

Get Discount on Asthma Devices Market Report@ https://www.marketresearchfuture.com/check-discount/1624 .

Europe is the second largest asthma devices market owing to a well-developed healthcare infrastructure and huge patient population. Moreover, government support for research & development and rising healthcare expenditures fuel the market growth. According to a study published in the Asthma Research and Practice journal in 2017, the yearly estimated cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the developed economies like the U.K, Germany, and France within the region boosts the market growth.

Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. According to a study of the Indian Chest Society in 2015, 300 million people suffered from asthma worldwide and about a tenth of its share is in India. Moreover, as per the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax along boosts the market growth.

LIST OF TABLES

Table 1 Global Asthma Devices Industry Synopsis, 2017 – 2023

Table 2 Global Asthma Devices Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Asthma Devices Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Asthma Devices Market By Type, 2017 – 2023, (USD Million)

Table 5 Global Asthma Devices Market By Technology, 2017 – 2023, (USD Million)

Table 6 Global Asthma Devices Market By End Users, 2017 – 2023, (USD Million)

Table 7 North America Global Asthma Devices Market By Type, 2017 – 2023, (USD Million)

Table 8 North America Global Asthma Devices Market By Technology, 2017 – 2023, (USD Million)

Table 9 North America Global Asthma Devices Market By End Users, 2017 – 2023, (USD Million)

Table 10 U.S. Global Asthma Devices Market By Type, 2017 – 2023, (USD Million)

And More.

Complete Report Details @ https://www.marketresearchfuture.com/reports/asthma-devices-market-1624 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.